APO Research
Talk to an analyst

APO RESEARCH · REPORT

Companion Animal Pharmaceutical

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Companion Animal Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchCompanion Animal Pharmaceutical Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animal Pharmaceutical Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Companion Animal Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animal Pharmaceutical Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animal Pharmaceutical Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Companion Animal Pharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Companion Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Companion Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Companion Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Companion Animal Pharmaceutical include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Ouro Fino Saude, Parnell, Vetoquinol and Virbac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Companion Animal Pharmaceutical market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Companion Animal Pharmaceutical and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Companion Animal Pharmaceutical revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Companion Animal Pharmaceutical market size, projected growth trends, production technologies, key applications, and end-use industries.

Companion Animal Pharmaceutical Segment by Company

Boehringer Ingelheim

Ceva

Dechra Veterinary Products

Elanco Animal Health

Meiji

Ouro Fino Saude

Parnell

Vetoquinol

Virbac

Zoetis

Bayer Animal Health

Merck Animal Health

Companion Animal Pharmaceutical Segment by Type

Infectious Diseases

Orthopedic Diseases

Dermatologic Diseases

Pain

Behavioral Diseases

Other Indications

Companion Animal Pharmaceutical Segment by Application

Dogs

Cats

Other

Companion Animal Pharmaceutical Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Companion Animal Pharmaceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Companion Animal Pharmaceutical industry.

Chapter 3: Detailed analysis of Companion Animal Pharmaceutical companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Companion Animal Pharmaceuticalrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Companion Animal Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Infectious Diseases Table 3. Key Players of Orthopedic Diseases Table 4. Key Players of Dermatologic Diseases Table 3. Key Players of Pain Table 4. Key Players of Behavioral Diseases Table 5. Key Players of Other Indications Table 6. Global Companion Animal Pharmaceutical Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Dogs Table 8. Key Players of Cats Table 9. Key Players of Other Table 10. Global Companion Animal Pharmaceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Companion Animal Pharmaceutical Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Companion Animal Pharmaceutical Market Share by Region (2021-2026) Table 13. Global Companion Animal Pharmaceutical Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Companion Animal Pharmaceutical Market Share by Region (2027-2032) Table 15. Companion Animal Pharmaceutical Industry Trends Table 16. Companion Animal Pharmaceutical Industry Drivers Table 17. Companion Animal Pharmaceutical Industry Opportunities and Challenges Table 18. Companion Animal Pharmaceutical Industry Restraints Table 19. Global Companion Animal Pharmaceutical Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Companion Animal Pharmaceutical Revenue Market Share by Company (2021-2026) Table 21. Global Companion Animal Pharmaceutical Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Companion Animal Pharmaceutical Key Company Head Office and Area Served Table 23. Global Companion Animal Pharmaceutical Company, Product Type & Application Table 24. Global Companion Animal Pharmaceutical Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Companion Animal Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Companion Animal Pharmaceutical Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Companion Animal Pharmaceutical Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Companion Animal Pharmaceutical Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Companion Animal Pharmaceutical Revenue Market Share by Type (2021-2026) Table 31. Global Companion Animal Pharmaceutical Revenue Market Share by Type (2027-2032) Table 32. Global Companion Animal Pharmaceutical Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Companion Animal Pharmaceutical Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Companion Animal Pharmaceutical Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Companion Animal Pharmaceutical Revenue Market Share by Application (2021-2026) Table 36. Global Companion Animal Pharmaceutical Revenue Market Share by Application (2027-2032) Table 37. Boehringer Ingelheim Company Information Table 38. Boehringer Ingelheim Business Overview Table 39. Boehringer Ingelheim Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Boehringer Ingelheim Companion Animal Pharmaceutical Product Portfolio Table 41. Boehringer Ingelheim Recent Development Table 42. Ceva Company Information Table 43. Ceva Business Overview Table 44. Ceva Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Ceva Companion Animal Pharmaceutical Product Portfolio Table 46. Ceva Recent Development Table 47. Dechra Veterinary Products Company Information Table 48. Dechra Veterinary Products Business Overview Table 49. Dechra Veterinary Products Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Dechra Veterinary Products Companion Animal Pharmaceutical Product Portfolio Table 51. Dechra Veterinary Products Recent Development Table 52. Elanco Animal Health Company Information Table 53. Elanco Animal Health Business Overview Table 54. Elanco Animal Health Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Elanco Animal Health Companion Animal Pharmaceutical Product Portfolio Table 56. Elanco Animal Health Recent Development Table 57. Meiji Company Information Table 58. Meiji Business Overview Table 59. Meiji Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Meiji Companion Animal Pharmaceutical Product Portfolio Table 61. Meiji Recent Development Table 62. Ouro Fino Saude Company Information Table 63. Ouro Fino Saude Business Overview Table 64. Ouro Fino Saude Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Ouro Fino Saude Companion Animal Pharmaceutical Product Portfolio Table 66. Ouro Fino Saude Recent Development Table 67. Parnell Company Information Table 68. Parnell Business Overview Table 69. Parnell Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Parnell Companion Animal Pharmaceutical Product Portfolio Table 71. Parnell Recent Development Table 72. Vetoquinol Company Information Table 73. Vetoquinol Business Overview Table 74. Vetoquinol Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Vetoquinol Companion Animal Pharmaceutical Product Portfolio Table 76. Vetoquinol Recent Development Table 77. Virbac Company Information Table 78. Virbac Business Overview Table 79. Virbac Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Virbac Companion Animal Pharmaceutical Product Portfolio Table 81. Virbac Recent Development Table 82. Zoetis Company Information Table 83. Zoetis Business Overview Table 84. Zoetis Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Zoetis Companion Animal Pharmaceutical Product Portfolio Table 86. Zoetis Recent Development Table 87. Bayer Animal Health Company Information Table 88. Bayer Animal Health Business Overview Table 89. Bayer Animal Health Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Bayer Animal Health Companion Animal Pharmaceutical Product Portfolio Table 91. Bayer Animal Health Recent Development Table 92. Merck Animal Health Company Information Table 93. Merck Animal Health Business Overview Table 94. Merck Animal Health Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Merck Animal Health Companion Animal Pharmaceutical Product Portfolio Table 96. Merck Animal Health Recent Development Table 97. North America Companion Animal Pharmaceutical Market Size by Type (2021-2026) & (US$ Million) Table 98. North America Companion Animal Pharmaceutical Market Size by Type (2027-2032) & (US$ Million) Table 99. North America Companion Animal Pharmaceutical Market Size by Application (2021-2026) & (US$ Million) Table 100. North America Companion Animal Pharmaceutical Market Size by Application (2027-2032) & (US$ Million) Table 101. North America Companion Animal Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Companion Animal Pharmaceutical Market Size by Country (2021-2026) Table 103. North America Companion Animal Pharmaceutical Market Size by Country (2027-2032) Table 104. Europe Companion Animal Pharmaceutical Market Size by Type (2021-2026) & (US$ Million) Table 105. Europe Companion Animal Pharmaceutical Market Size by Type (2027-2032) & (US$ Million) Table 106. Europe Companion Animal Pharmaceutical Market Size by Application (2021-2026) & (US$ Million) Table 107. Europe Companion Animal Pharmaceutical Market Size by Application (2027-2032) & (US$ Million) Table 108. Europe Companion Animal Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Companion Animal Pharmaceutical Market Size by Country (2021-2026) Table 110. Europe Companion Animal Pharmaceutical Market Size by Country (2027-2032) Table 111. China Companion Animal Pharmaceutical Market Size by Type (2021-2026) & (US$ Million) Table 112. China Companion Animal Pharmaceutical Market Size by Type (2027-2032) & (US$ Million) Table 113. China Companion Animal Pharmaceutical Market Size by Application (2021-2026) & (US$ Million) Table 114. China Companion Animal Pharmaceutical Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Companion Animal Pharmaceutical Market Size by Type (2021-2026) & (US$ Million) Table 116. Asia Companion Animal Pharmaceutical Market Size by Type (2027-2032) & (US$ Million) Table 117. Asia Companion Animal Pharmaceutical Market Size by Application (2021-2026) & (US$ Million) Table 118. Asia Companion Animal Pharmaceutical Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Companion Animal Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Companion Animal Pharmaceutical Market Size by Country (2021-2026) Table 121. Asia Companion Animal Pharmaceutical Market Size by Country (2027-2032) Table 122. South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Type (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Type (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2021-2026) Table 128. South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Companion Animal Pharmaceutical Product Image Figure 2. Global Companion Animal Pharmaceutical Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Companion Animal Pharmaceutical Market Share by Type: 2025 VS 2032 Figure 4. Infectious Diseases Image Figure 5. Orthopedic Diseases Image Figure 6. Dermatologic Diseases Image Figure 7. Pain Image Figure 8. Behavioral Diseases Image Figure 9. Other Indications Image Figure 10. Global Companion Animal Pharmaceutical Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Companion Animal Pharmaceutical Market Share by Application: 2025 VS 2032 Figure 12. Dogs Image Figure 13. Cats Image Figure 14. Other Image Figure 15. Global Companion Animal Pharmaceutical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 17. Global Companion Animal Pharmaceutical Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Companion Animal Pharmaceutical Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Companion Animal Pharmaceutical Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Companion Animal Pharmaceutical Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Companion Animal Pharmaceutical Revenue Market Share by Type (2021-2032) Figure 24. Global Companion Animal Pharmaceutical Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Companion Animal Pharmaceutical Revenue Market Share by Application (2021-2032) Figure 26. North America Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 27. North America Companion Animal Pharmaceutical Market Share by Type (2021-2032) Figure 28. North America Companion Animal Pharmaceutical Market Share by Application (2021-2032) Figure 29. North America Companion Animal Pharmaceutical Market Share by Country (2021-2032) Figure 30. United States Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 31. Canada Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 33. Europe Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 34. Europe Companion Animal Pharmaceutical Market Share by Type (2021-2032) Figure 35. Europe Companion Animal Pharmaceutical Market Share by Application (2021-2032) Figure 36. Europe Companion Animal Pharmaceutical Market Share by Country (2021-2032) Figure 37. Germany Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 38. France Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 40. Italy Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 41. Russia Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 43. China Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 44. China Companion Animal Pharmaceutical Market Share by Type (2021-2032) Figure 45. China Companion Animal Pharmaceutical Market Share by Application (2021-2032) Figure 46. Asia Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 47. Asia Companion Animal Pharmaceutical Market Share by Type (2021-2032) Figure 48. Asia Companion Animal Pharmaceutical Market Share by Application (2021-2032) Figure 49. Asia Companion Animal Pharmaceutical Market Share by Country (2021-2032) Figure 50. Japan Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 54. India Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 55. Australia Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Companion Animal Pharmaceutical Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Companion Animal Pharmaceutical Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Companion Animal Pharmaceutical Market Share by Country (2021-2032) Figure 60. Brazil Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 65. UAE Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 67. Chile Companion Animal Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Infectious Diseases
  • Orthopedic Diseases
  • Dermatologic Diseases
  • Pain
  • Behavioral Diseases
  • Other Indications
Applications
  • Dogs
  • Cats
  • Other
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Dechra Veterinary Products
  • Elanco Animal Health
  • Meiji
  • Ouro Fino Saude
  • Parnell
  • Vetoquinol
  • Virbac
  • Zoetis
  • Bayer Animal Health
  • Merck Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Infectious Diseases
  5. 1.2.3 Orthopedic Diseases
  6. 1.2.4 Dermatologic Diseases
  7. 1.2.5 Pain
  8. 1.2.6 Behavioral Diseases
  9. 1.2.7 Other Indications
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Dogs
  13. 1.3.3 Cats
  14. 1.3.4 Other
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Companion Animal Pharmaceutical Growth Trends by Region
  17. 1.5.1 Global Companion Animal Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Companion Animal Pharmaceutical Market Size by Region (2021-2026)
  19. 1.5.3 Companion Animal Pharmaceutical Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Companion Animal Pharmaceutical Market Dynamics
  1. 2.1 Companion Animal Pharmaceutical Industry Trends
  2. 2.2 Companion Animal Pharmaceutical Industry Drivers
  3. 2.3 Companion Animal Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 Companion Animal Pharmaceutical Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Companion Animal Pharmaceutical Revenue by Company (2021-2026)
  2. 3.2 Global Companion Animal Pharmaceutical Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Companion Animal Pharmaceutical Key Company Head office and Area Served
  4. 3.4 Global Companion Animal Pharmaceutical Company, Product Type & Application
  5. 3.5 Global Companion Animal Pharmaceutical Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Companion Animal Pharmaceutical Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Companion Animal Pharmaceutical Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Companion Animal Pharmaceutical Tier 1, Tier 2, and Tier 3
4 Companion Animal Pharmaceutical Market by Type
  1. 4.1 Global Companion Animal Pharmaceutical Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Companion Animal Pharmaceutical Market Size by Type (2021-2032)
  3. 4.3 Global Companion Animal Pharmaceutical Market Size Share by Type (2021-2032)
5 Companion Animal Pharmaceutical Market by Application
  1. 5.1 Global Companion Animal Pharmaceutical Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Companion Animal Pharmaceutical Market Size by Application (2021-2032)
  3. 5.3 Global Companion Animal Pharmaceutical Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Companion Animal Pharmaceutical Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Ceva
  8. 6.2.1 Ceva Company Information
  9. 6.2.2 Ceva Business Overview
  10. 6.2.3 Ceva Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Ceva Companion Animal Pharmaceutical Product Portfolio
  12. 6.2.5 Ceva Recent Developments
  13. 6.3 Dechra Veterinary Products
  14. 6.3.1 Dechra Veterinary Products Company Information
  15. 6.3.2 Dechra Veterinary Products Business Overview
  16. 6.3.3 Dechra Veterinary Products Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Dechra Veterinary Products Companion Animal Pharmaceutical Product Portfolio
  18. 6.3.5 Dechra Veterinary Products Recent Developments
  19. 6.4 Elanco Animal Health
  20. 6.4.1 Elanco Animal Health Company Information
  21. 6.4.2 Elanco Animal Health Business Overview
  22. 6.4.3 Elanco Animal Health Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Elanco Animal Health Companion Animal Pharmaceutical Product Portfolio
  24. 6.4.5 Elanco Animal Health Recent Developments
  25. 6.5 Meiji
  26. 6.5.1 Meiji Company Information
  27. 6.5.2 Meiji Business Overview
  28. 6.5.3 Meiji Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Meiji Companion Animal Pharmaceutical Product Portfolio
  30. 6.5.5 Meiji Recent Developments
  31. 6.6 Ouro Fino Saude
  32. 6.6.1 Ouro Fino Saude Company Information
  33. 6.6.2 Ouro Fino Saude Business Overview
  34. 6.6.3 Ouro Fino Saude Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Ouro Fino Saude Companion Animal Pharmaceutical Product Portfolio
  36. 6.6.5 Ouro Fino Saude Recent Developments
  37. 6.7 Parnell
  38. 6.7.1 Parnell Company Information
  39. 6.7.2 Parnell Business Overview
  40. 6.7.3 Parnell Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Parnell Companion Animal Pharmaceutical Product Portfolio
  42. 6.7.5 Parnell Recent Developments
  43. 6.8 Vetoquinol
  44. 6.8.1 Vetoquinol Company Information
  45. 6.8.2 Vetoquinol Business Overview
  46. 6.8.3 Vetoquinol Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Vetoquinol Companion Animal Pharmaceutical Product Portfolio
  48. 6.8.5 Vetoquinol Recent Developments
  49. 6.9 Virbac
  50. 6.9.1 Virbac Company Information
  51. 6.9.2 Virbac Business Overview
  52. 6.9.3 Virbac Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Virbac Companion Animal Pharmaceutical Product Portfolio
  54. 6.9.5 Virbac Recent Developments
  55. 6.10 Zoetis
  56. 6.10.1 Zoetis Company Information
  57. 6.10.2 Zoetis Business Overview
  58. 6.10.3 Zoetis Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Zoetis Companion Animal Pharmaceutical Product Portfolio
  60. 6.10.5 Zoetis Recent Developments
  61. 6.11 Bayer Animal Health
  62. 6.11.1 Bayer Animal Health Company Information
  63. 6.11.2 Bayer Animal Health Business Overview
  64. 6.11.3 Bayer Animal Health Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Bayer Animal Health Companion Animal Pharmaceutical Product Portfolio
  66. 6.11.5 Bayer Animal Health Recent Developments
  67. 6.12 Merck Animal Health
  68. 6.12.1 Merck Animal Health Company Information
  69. 6.12.2 Merck Animal Health Business Overview
  70. 6.12.3 Merck Animal Health Companion Animal Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Merck Animal Health Companion Animal Pharmaceutical Product Portfolio
  72. 6.12.5 Merck Animal Health Recent Developments
7 North America
  1. 7.1 North America Companion Animal Pharmaceutical Market Size (2021-2032)
  2. 7.2 North America Companion Animal Pharmaceutical Market Size by Type
  3. 7.2.1 North America Companion Animal Pharmaceutical Market Size by Type (2021-2026)
  4. 7.2.2 North America Companion Animal Pharmaceutical Market Size by Type (2027-2032)
  5. 7.2.3 North America Companion Animal Pharmaceutical Market Share by Type (2021-2032)
  6. 7.3 North America Companion Animal Pharmaceutical Market Size by Application
  7. 7.3.1 North America Companion Animal Pharmaceutical Market Size by Application (2021-2026)
  8. 7.3.2 North America Companion Animal Pharmaceutical Market Size by Application (2027-2032)
  9. 7.3.3 North America Companion Animal Pharmaceutical Market Share by Application (2021-2032)
  10. 7.4 North America Companion Animal Pharmaceutical Market Size by Country
  11. 7.4.1 North America Companion Animal Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Companion Animal Pharmaceutical Market Size by Country (2021-2026)
  13. 7.4.3 North America Companion Animal Pharmaceutical Market Size by Country (2027-2032)
  14. 7.4.4 North America Companion Animal Pharmaceutical Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Companion Animal Pharmaceutical Market Size (2021-2032)
  2. 8.2 Europe Companion Animal Pharmaceutical Market Size by Type
  3. 8.2.1 Europe Companion Animal Pharmaceutical Market Size by Type (2021-2026)
  4. 8.2.2 Europe Companion Animal Pharmaceutical Market Size by Type (2027-2032)
  5. 8.2.3 Europe Companion Animal Pharmaceutical Market Share by Type (2021-2032)
  6. 8.3 Europe Companion Animal Pharmaceutical Market Size by Application
  7. 8.3.1 Europe Companion Animal Pharmaceutical Market Size by Application (2021-2026)
  8. 8.3.2 Europe Companion Animal Pharmaceutical Market Size by Application (2027-2032)
  9. 8.3.3 Europe Companion Animal Pharmaceutical Market Share by Application (2021-2032)
  10. 8.4 Europe Companion Animal Pharmaceutical Market Size by Country
  11. 8.4.1 Europe Companion Animal Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Companion Animal Pharmaceutical Market Size by Country (2021-2026)
  13. 8.4.3 Europe Companion Animal Pharmaceutical Market Size by Country (2027-2032)
  14. 8.4.4 Europe Companion Animal Pharmaceutical Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Companion Animal Pharmaceutical Market Size (2021-2032)
  2. 9.2 China Companion Animal Pharmaceutical Market Size by Type
  3. 9.2.1 China Companion Animal Pharmaceutical Market Size by Type (2021-2026)
  4. 9.2.2 China Companion Animal Pharmaceutical Market Size by Type (2027-2032)
  5. 9.2.3 China Companion Animal Pharmaceutical Market Share by Type (2021-2032)
  6. 9.3 China Companion Animal Pharmaceutical Market Size by Application
  7. 9.3.1 China Companion Animal Pharmaceutical Market Size by Application (2021-2026)
  8. 9.3.2 China Companion Animal Pharmaceutical Market Size by Application (2027-2032)
  9. 9.3.3 China Companion Animal Pharmaceutical Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Companion Animal Pharmaceutical Market Size (2021-2032)
  2. 10.2 Asia Companion Animal Pharmaceutical Market Size by Type
  3. 10.2.1 Asia Companion Animal Pharmaceutical Market Size by Type (2021-2026)
  4. 10.2.2 Asia Companion Animal Pharmaceutical Market Size by Type (2027-2032)
  5. 10.2.3 Asia Companion Animal Pharmaceutical Market Share by Type (2021-2032)
  6. 10.3 Asia Companion Animal Pharmaceutical Market Size by Application
  7. 10.3.1 Asia Companion Animal Pharmaceutical Market Size by Application (2021-2026)
  8. 10.3.2 Asia Companion Animal Pharmaceutical Market Size by Application (2027-2032)
  9. 10.3.3 Asia Companion Animal Pharmaceutical Market Share by Application (2021-2032)
  10. 10.4 Asia Companion Animal Pharmaceutical Market Size by Country
  11. 10.4.1 Asia Companion Animal Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Companion Animal Pharmaceutical Market Size by Country (2021-2026)
  13. 10.4.3 Asia Companion Animal Pharmaceutical Market Size by Country (2027-2032)
  14. 10.4.4 Asia Companion Animal Pharmaceutical Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Companion Animal Pharmaceutical Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Companion Animal Pharmaceutical Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Companion Animal Pharmaceutical Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst